1.
Setiawati A, Darmansjah I, Mangunnegoro H. Safety and tolerability of moxifloxacin in the treatment of respiratory tract infections: a post-marketing surveillance conducted in Indonesia. Med J Indones [Internet]. 2005Feb.1 [cited 2022Nov.27];14(1):11-9. Available from: http://mji.ui.ac.id/journal/index.php/mji/article/view/168